Your browser doesn't support javascript.
loading
The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial.
Pollack, Alan; Karrison, Theodore G; Balogh, Alexander G; Gomella, Leonard G; Low, Daniel A; Bruner, Deborah W; Wefel, Jeffrey S; Martin, Andre-Guy; Michalski, Jeff M; Angyalfi, Steve J; Lukka, Himanshu; Faria, Sergio L; Rodrigues, George B; Beauchemin, Marie-Claude; Lee, R Jeffrey; Seaward, Samantha A; Allen, Aaron M; Monitto, Drew C; Seiferheld, Wendy; Sartor, Oliver; Feng, Felix; Sandler, Howard M.
Afiliação
  • Pollack A; Department of Radiation Oncology, University of Miami Miller School of Medicine and Sylvester Comprehensive Cancer Center, Miami, FL, USA. Electronic address: apollack@med.miami.edu.
  • Karrison TG; Department of Public Health Sciences, University of Chicago, Chicago, IL, USA; NRG Oncology, Philadelphia, PA, USA.
  • Balogh AG; Tom Baker Cancer Center, University of Calgary, Calgary, AB, Canada.
  • Gomella LG; Sidney Kimmel Cancer Center of Thomas Jefferson University, Philadelphia, PA, USA.
  • Low DA; Department of Radiation Oncology, University of California at Los Angeles, Los Angeles, CA, USA.
  • Bruner DW; Nell Hodgson Woodruff School of Nursing, and Winship Cancer Institute at Emory University, Atlanta, GA, USA.
  • Wefel JS; Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Martin AG; CHU de Quebec-Université Laval (L'Hotel-Dieu de Quebec), Quebec, QC, Canada.
  • Michalski JM; Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO, USA.
  • Angyalfi SJ; Tom Baker Cancer Center, University of Calgary, Calgary, AB, Canada.
  • Lukka H; Department of Oncology, McMaster University, Hamilton, ON, Canada.
  • Faria SL; McGill University Health Centre, Montreal, QC, Canada.
  • Rodrigues GB; Department of Oncology, London Regional Cancer Program, Western University, London, ON, Canada.
  • Beauchemin MC; Department of Radiation Oncology, CHUM-Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.
  • Lee RJ; Intermountain Medical Center, Salt Lake City, UT, USA.
  • Seaward SA; Kaiser Permanente-Vallejo, Vallejo, CA, USA.
  • Allen AM; Davidoff Center, Rabin Medical Center, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Monitto DC; Spartanburg Regional Medical Center, Spartanburg, SC, USA.
  • Seiferheld W; NRG Oncology, Philadelphia, PA, USA.
  • Sartor O; Department of Medicine, Tulane University, New Orleans, LA, USA.
  • Feng F; Department of Radiation Oncology, University of California at San Francisco, San Francisco, CA , USA.
  • Sandler HM; Cedars Sinai Medical Center, Los Angeles, CA, USA.
Lancet ; 399(10338): 1886-1901, 2022 05 14.
Article em En | MEDLINE | ID: mdl-35569466
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Radioterapia (Especialidade) Tipo de estudo: Clinical_trials / Guideline Limite: Adolescent / Adult / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Radioterapia (Especialidade) Tipo de estudo: Clinical_trials / Guideline Limite: Adolescent / Adult / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article